A modified method for preparation of adriamycin carried by magnetic albumin microspheres

Abstract

The targeting of antineoplastic agents to restricted anatomic sites and specific target cells have been challenged clinicians all the time in cancer chemotherapy, which resulted in recent efforts to focus the effects of existing antitumor agents and treatments on tumor cells and spare their effects on normal cells. The drug-carrier complex, adriamycin carried by magnetic albumin microspheres (ADM-MAM) was prepared by using our discovered new and modified method. The physical feature of the prepared drug-carrier microspheres was much better than by the traditional method in comparison. The successful preparation of the drug-carrier complex, ADM-MAM, is one of the key steps for our later further researches in the targeted chemotherapy.

Keywords

adriamycin / targeted chemotherapy / magnetic albumin microspheres

References

[1] WidderK, FlouretG, SenyeiA. Magnetic microspheres synthesis of a novel parenteral drug carrier. J Pharm Sci, 1979, 4679-79

[2] KatoT, NematoR, MoriH, et al. . Sustained-release properties of microencapsulated mitomycin C with wingethylcellulosse infused into the renal artery of the dog. Cancer, 1980, 4614-14

[3] WidderK J, SenyeiA, RannayD F. In vitro release of biologically active adrimycin by magnetically responsive albumin microspheres. Cancer Research, 1980, 403512-3512

[4] WidderK J. Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin microspheres containing doxorubicin. Proc Natl Acad Sci USA, 1981, 78(1): 579-579

[5] WidderK J. Magnetically responsive microspheres. Adv Pharmal Chemother, 1979, 16256-256

[6] IbrahimA, CoxrerurP, RolandM, et al. . New magnetic drug carrier. J Pharm Pharmacol, 1983, 3559-59

[7] WidderK J, SenyeiA E, OvadiaH, et al. . Magnetic protein A microspheres: a rapid method for cell separation. Clin Immunol Immunopathol, 1979, 14(3): 395-395

[8] WidderK J, SenyeiA E, RanneyD F. Magnetically responsive microspheres and other carriers for the biophysical targeting for antitumor agents. Adv Pharmacol Chemother, 1979, 16213-213